Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01796873 · ClinicalTrials.gov registry record
Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention
A clinical trial, sponsored by University of Arizona.
- Completed
- Registry status
- 36
- Enrollment target
NCT01796873 is a clinical trial that has completed, run by University of Arizona. The registered enrollment target is 36 participants.
The verdict
NCT01796873 has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
Plavix (clopidogrel) is a drug that is approved by the FDA (Food and Drug Administration) to reduce the risk of having another heart attack by preventing platelets (blood cells that are important in forming blood clots) from sticking together and forming another clot. Platelet activity can be measured by a machine called VerifyNow. The purpose of this study is to see whether Hispanic women and White non-Hispanic women have the same platelet response to a commonly used drug, Plavix (clopidogrel). Recent studies have shown that platelets may be more active in Hispanics, making it more difficult to prevent clots from forming, even when using Plavix. In addition, studies have shown that women may also have more active platelets than men. There have been no studies of Hispanic women and the effect of Plavix on platelet activity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01796873
The ClinicalTrials.gov registry entry for NCT01796873 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01796873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01796873 about?
NCT01796873 is a clinical study titled "Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention". Plavix (clopidogrel) is a drug that is approved by the FDA (Food and Drug Administration) to reduce the risk of having another heart attack by preventing platelets (blood cells that are important in forming blood clots) from sticking together and forming another clot. Platelet activity can be measur...
What is the current status of trial NCT01796873?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2012-01. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01796873?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.